Pfizer, Chinese partner to sell local brand of Paxlovid

  • 📰 fmtoday
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 72%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Pfizer, China drugmaker to sell local brand of Paxlovid FMTNews FMTBusiness

Pfizer’s Paxlovid cooperation with CSPC Pharmaceutical Group is the latest in its expansion efforts in China.

CSPC, which earlier this year won approval from Chinese regulators for the country’s first locally developed mRNA Covid vaccine, will manufacture and sell the medication in mainland China, according to a Pfizer spokesperson. That coincided with a surge in demand for antivirals after Beijing’s abrupt dismantling of most Covid restrictions in late 2022 unleashed a virus wave that infected 80% of the population in less than two months.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 5. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Applying science to TCM for natural pain reliefThe secrets of a centuries-old traditional Chinese medicine formulation are unlocked using scientific methods.
Source: staronline - 🏆 4. / 75 Read more »